Biogen (BIIB) EPS (Diluted) (2009 - 2026)
Biogen (BIIB) EPS (Diluted) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.03 Bn | 634.27 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 470.29 Bn | 463.72 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 380.80 Bn | 373.66 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 302.80 Bn | 295.11 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 258.24 Bn | 253.34 Bn | 12.86 Bn | 1.61 |
| 6 | Amgen | 237.40 Bn | 223.41 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 183.07 Bn | 179.89 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 161.54 Bn | 149.84 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 106.01 Bn | 101.85 Bn | 8.24 Bn | 0.28 |
| 10 | Biogen | 32.22 Bn | 30.94 Bn | 1.96 Bn | 0.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.66 |
| Mar 31, 2026 | 2.15 |
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | 3.17 |
| Jun 30, 2025 | 4.33 |
| Mar 31, 2025 | 1.64 |
| Dec 31, 2024 | 1.83 |
| Sep 30, 2024 | 2.66 |
| Jun 30, 2024 | 4.00 |
| Mar 31, 2024 | 2.70 |
| Dec 31, 2023 | 1.71 |
| Sep 30, 2023 | -0.47 |
| Jun 30, 2023 | 4.08 |
| Mar 31, 2023 | 2.67 |
| Dec 31, 2022 | 3.76 |
| Sep 30, 2022 | 7.84 |
| Jun 30, 2022 | 7.20 |
| Mar 31, 2022 | 1.50 |
| Dec 31, 2021 | -0.26 |
| Sep 30, 2021 | 2.13 |